Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 920 results for "roche"

Bina Technologies is acquired by Roche.

Beta-amyloid: the emperor really does have no clothes

Yesterday, Roche (OTCQX:RHHBY) announced its decision to discontinue its Phase 3 study of gantenerumab, its experimental anti-amyloid antibody, in early Alzheimer's Disease. The study failed a futility analysis - the clearest possible evidence of a ... Austin American Statesman, 13 hours ago
Roche Holding to acquire Dutalys, 1 day ago

1,028 images for roche, 1 day ago
Live Trading News, 1 day ago
Bidness Etc, 1 day ago, 1 day ago
Today FM, 1 day ago
West Australian, 1 day ago
Toronto Star Online, 1 day ago
Pharmafocus, 1 day ago
Irish Independent, 2 days ago
Pharma Letter, 1 day ago

Roche Drugs For Alzheimer's, Breast Cancer Disappoint

Posted 11:31 AM ET Big Swiss pharma Roche (OTCPK:RHHBY) halted development of its Alzheimer's disease drug and reported mediocre results from a clinical trial of breast-cancer drug Kadcyla Friday, sending the stock down more than 6% in early ...
 Investor's Business Daily1 day ago Roche's Breast Cancer Drug Trial Fails  RTTNews.com1 day ago Roche cancer drug fails label expansion trial  Seeking Alpha1 day ago Roche shares tumble after Alzheimer's drug failure  Fortune1 day ago

Roche Halts Alzheimer's Drug Study On Stagnant Safety Profile

Roche Holding AG (RHHBY.PK) on Friday said it was halting a late-stage trial of its investigational drug gantenerumab to treat patients with early Alzheimer's disease as its overall safety profile was similar to that of a Phase 1 study. Roche shares ...
 RTTNews.com1 day ago

ImmunoGen Inc. (IMGN) Is Sharply Lower After Roche Study Disappoints

Roche reported early Friday morning that neither of the Kadcyla-containing treatment arms in its Phase 3 study of the drug significantly improved PFS compared to Herceptin and chemotherapy. Kadcyla utilizes ImmunoGen's (IMGN: Quote) ADC technology. ...
 RTTNews.com1 day ago Disappointing study results for ImmunoGen  Pettinga Financial Advisors1 day ago
Bidness Etc

Roche Holding Stock Declines As Alzheimer's, Breast Cancer Treatments Fail Clinical Trials

It wasn't Roche Holding Ltd.'s (ADR) ( OTCMKTS:RHHBY ) finest day. The company posted unsatisfactory results from clinical trials of two experimental treatments an Alzheimer's treatment and one for HER-2 breast cancer. The stock tumbled as a ...
 Bidness Etc1 day ago

ImmunoGen tanks on Roche Phase 3 failure

ImmunoGen (NASDAQ:IMGN) plummets 40% premarket on robust volume in response to Roche's (OTCQX:RHHBY) announcement that its Phase 3 trial evaluating Kadcyla (trastuzumab emtansine) failed to significantly improve progression-free survival as a ...
 Seeking Alpha1 day ago ImmunoGen, Inc. (IMGN) Reports Roche (RHHBY) Has Provided An Update On The MARIANNE Trial 12/19/2014  ClinicSpace1 day ago Roche and Italian banks stymie European share rebound  Sharenet1 day ago Benzinga's Top #PreMarket Losers  Benzinga.com1 day ago

Volume Spike Detected in Shares of Roche Holding as They Move Lower on 6.6x Above-Average Volume (RHHBY)

(Financial News Network On) Shares of Roche Holding are trading today in above average volume, with the share price falling 39.9% to $34.33. Today's volume of 5.5 million shares tops the average 30-day volume of 839,000 shares. Unusually high ...
 Individual.com1 day ago

Double revers pour Roche sur Alzheimer et le cancer du sein

Mining Industry News and Mining press releases from public and private companies. Mining Newswire accepts press releases and headline news. Unlimited Mass Media SEO Press Release Distribution with Guaranteed Results U.S. National Distribution. ...
 Africa News Wire1 day ago

European shares pause, hit by drop in Roche and Italian banks

* FTSEurofirst 300 flat after Thursday's 3 pct rally * Roche hit as two drugs fail tests * Air France tumbles after third profit warning (Recasts, adds details, quote) LONDON, Dec 19 (Reuters) - European stocks held steady on Friday, ...
 CNBC1 day ago

Roche Scraps Alzheimer's Drug Trial on Disappointing Results

Roche Holding AG (ROG) said a trial of an experimental medicine for Alzheimer's disease yielded disappointing results, adding to a long list of failures in the effort to find a treatment for the leading cause of dementia. The study of ...
 Bloomberg1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less